Peroxynitrite modified DNA presents better epitopes for anti-DNA autoantibodies in diabetes type 1 patients

Cellular Immunology

Volumn 290, Issue 1, 2014, Pages 30-38

  Tripathi, Prashant ^a   Moinuddin, ^a   Dixit, Kiran ^a   Mir, Abdul Rouf ^a   Habib, Safia ^a   Alam, Khursheed ^a   Ali, Asif ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Antibodies; Diabetes; DNA damage; Peroxynitrite

Indexed keywords

8 NITROGUANINE; DNA ANTIBODY; IMMUNOGLOBULIN G; NITRITE; PEROXYNITRITE; PLASMID DNA;

ADOLESCENT; ADULT; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; BLOOD LEVEL; CHILD; CIRCULAR DICHROISM; COMPETITIVE INHIBITION; CONTROLLED STUDY; DIABETIC PATIENT; DIABETOGENESIS; DNA BASE COMPOSITION; DNA DAMAGE; DNA STRAND BREAKAGE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FLUORESCENCE SPECTROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MELTING POINT; NITROSATIVE STRESS; NONHUMAN; PRIORITY JOURNAL; TEMPERATURE; ULTRAVIOLET SPECTROSCOPY;

ANTIBODIES; DIABETES; DNA DAMAGE; PEROXYNITRITE;

ANTIBODIES, ANTINUCLEAR; DIABETES MELLITUS, TYPE 1; DNA; DNA ADDUCTS; DNA BREAKS; EPITOPES; GUANINE; HUMANS; IMMUNOGLOBULIN G; NITRITES; PEROXYNITROUS ACID; PLASMIDS;

EID: 84901299065     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2014.04.012     Document Type: Article

References (40)

1. Pacher P., Beckman J.S., Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 2007, 87:315-324.
2. Habib S., Moinuddin, Ali A., Ali R. Preferential recognition of peroxynitrite modified human DNA by circulating autoantibodies in cancer patients. Cell Immunol. 2009, 254:117-123.
3. Szabo G., Bahrle S. Role of nitrosative stress and poly(ADP-ribose) polymerase activation in myocardial reperfusion injury. Curr. Vasc. Pharmacol. 2005, 3:215-220.
4. Garcia-Garcia A., Rodriguez-Rocha H., Madayiputhiya N., Pappa A., Panayiotidis M.I., Franco R. Biomarkers of protein oxidation in human disease. Curr Mol Med. 2012, 12(6):681-697.
5. Lupachyk S., Shevalye H., Maksimchyk Y., Drel V.R., Obrosova I.G. PARP inhibition alleviates diabetes-induced systemic oxidative stress and neural tissue 4-hydroxynonenal adduct accumulation: correlation with peripheral nerve function. Free Radical Biol. Med. 2011, 50:1400-1409.
6. Yoon J.W., Jun H.S. Autoimmune destruction of pancreatic beta cells. Am. J. Ther. 2005, 12:580-591.
7. Botero D., Wolfsdorf J.I. Diabetes mellitus in children and adolescents. Arch. Med. Res. 2005, 36:281-290.
8. Bingley P.J., Bonifacio E., Ziegler A.G., Schatz D.A., Atkinson M.A., Eisenbarth G.S. Proposed guidelines on screening for risk of type 1 diabetes. Diabetes Care 2001, 24:398.
9. Pacher P., Obrosova I.G., Mabley J.G., Szabo C. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetes complications. Emerging new therapeutical strategies. Curr. Med. Chem. 2005, 12:267-275.
10. Pacher P., Liaudet L., Soriano F.G., Mabley J.G., Szabo E., Szabo C. The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction indiabetes. Diabetes 2002, 51:514-521.
11. Pacher P., Szabo C. Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetes complications: endothelial dysfunction, as a common underlying theme. Antioxid. Redox Signal. 2005, 7:1568-1580.
12. Kiss L., Szabo C. The pathogenesis of diabetes complications: the role of DNA injury and poly(ADP-ribose) polymerase activation in peroxynitrite-mediated cytotoxicity. Mem. Inst. Oswaldo Cruz 2005, 100:29-37.
13. Uchigata Y., Yamamoto H., Kawamura A., Okamoto H. Protection by superoxide dismutase, catalase, and poly(ADP-ribose) synthetase inhibitors against alloxan- and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis. J. Biol. Chem. 1982, 257:6084-6098.
14. Koppenol W.H., Kissner R., Beckman S. Synthesis of peroxynitrite: to go with the flow or on solid grounds. Methods Enzymol. 1994, 269:296-302.
15. Dixit K., Moinuddin, Ali A. Immunological studies on peroxynitrite modified human DNA. Life Sci. 2005, 77(21):2626-2642.
16. 2+. Biochem. Biophys. Res. Commun. 2011, 407(3):568-574.
17. Matsuo N., Ross P.M. Measurement of interstrand cross-link frequency and distance between interruptions in DNA exposed to 4,5',8-trimethylpsoralen and near-ultraviolet light. Biochemistry 1987, 26:2001-2009.
18. Ashok B.T., Ali R. Binding of human anti-DNA autoantibodies to reactive oxygen species modified-DNA and probing oxidative DNA damage in cancer using monoclonal antibody. Int. J. Cancer 1998, 78:404-409.
19. Khan M.A., Dixit K., Jabeen S., Moinuddin, Alam K. Impact of peroxynitrite modification structure and immunogenicity of H2A histone. Scand. J. Immunol. 2008, 69:99-109.
20. Dixit K., Khan M.A., Sharma Y.D., Moinuddin, Alam K. Peroxynitrite-induced modification of H2A histone mimics epitopes which are strongly bound by human anti-DNA autoantibodies: role of peroxynitrite-modified-H2A in SLE induction and progression. Human Immunol. 2011, 72:219-225.
21. Alam K., Moinuddin, Jabeen S. Immunogenicity of mitochondrial DNA modified by hydroxyl radical. Cell Immunol. 2007, 247:12-17.
22. Dixit K., Ali R. Role of nitric oxide modified-DNA in the etiopathogenesis of systemic lupus erythematosus. Lupus 2004, 13:95-100.
23. Nicholas D.J.D., Nason A. Determination of nitrate and nitrite. Methods Enzymol. 1975, 3:982-994.
24. Chang T.J., Wang R., Wu L.Y. Methylglyoxal-induced nitric oxide and peroxynitrite production in vascular smooth muscle cells. Free Radical Biol. Med. 2005, 38:286-290.
25. Boulanger C.M. Secondary endothelial dysfunction: hypertension and heart failure. J. Mol. Cell. Cardiol. 1999, 31:39-49.
26. Grace S.C., Salgo M.G., Pryor W.A. Scavenging of peroxynitrite by a phenolic/peroxidase system prevents oxidative damage to DNA. FEBS Lett. 1998, 426:24-28.
27. Millar T.M. Peroxynitrite formation from the simultaneous reduction of nitrite and oxygen by xanthine oxidase. FEBS Lett. 2005, 562:129-131.
28. Zanchi A., Szabo C., Komjati K., Pacher P., Krolewski A.S., Quist W.C., LoGerfo F.W., Horton E.S., Veves A. Poly(ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation 2002, 106:2680-2686.
29. Pacher P., Beckman J.S., Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 2007, 87:315-324.
30. Szabo C. Roles of poly(ADP-ribose) polymerase activation in the pathogenesis of diabetes mellitus and its complications. Pharmacol. Res. 2005, 52:60-71.
31. Casperson G.F., Voss E.W. Specificity of anti-DNA antibodies in SLE-I. Definition and gross specificity of antibody populations in human SLE plasma. Mol. Immunol. 1983, 20:573-580.
32. Thomas R. The denaturation of DNA. Gene 1993, 135:77-79.
33. Szabo C., Ohshima H. DNA damage induced by peroxynitrite: subsequent biological effect. Nitric Oxide 1997, 1:373-385.
34. Wasserfall C.A., Atkinson M.A. Autoantibody markers for the diagnosis and prediction of type 1 diabetes. Autoimmun. Rev. 2006, 5:424-428.
35. Silva D.G., Daley S.R., Hogan J., Lee S.K. Anti-islet autoantibodies trigger autoimmune diabetes in the presence of an increased frequency of islet-reactive CD4 T cells. Diabetes 2011, 60:2102-2111.
36. Atli T., Keven K., Avci A., Kutlay S., Turkcapar N., Varli M., Aras S., Ertug E., Canbolat O. Oxidative stress and antioxidant status in elderly diabetes mellitus and glucose intolerance patients. Arch. Gerontol. Geriatr. 2004, 39(3):269-275.
37. Parthiban A., Vijayalingam S., Shanmugasundaram K.R., Mohan R. Oxidative stress and the development of diabetes complications. Antioxidants and lipid peroxidation in erythrocytes and cell membrane. Cell Biol. Int. 1995, 12:987-993.
38. Buyukkocak S., Ozturk H.S., Tamer M.N., Kacmaz M., Cimen M.Y., Durak I. Erythrocyte oxidant/antioxidant status of diabetes patients. J. Endocrinol. Invest. 2000, 4:228-230.
39. Doganay S., Evereklioglu C., Turkoz Y., Savli H. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye 2002, 16:163-170.
40. Robert D., Kimberly D.B., Hobbs G.R., Baylis C. Peroxynitrite versus nitric oxide in early diabetes. Am. J. Hyper. 2003, 16:761-766.